NYSE:WAT

Waters Corp (WAT)

383.57
+16.90 (4.61%)
as of May 29, 2026, 8:00:00 pm Market Open.
6 watching
0
Investor Insights
star iconMay 29, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Waters Corp (WAT-N) has experienced a turbulent year following its acquisition of a segment of Becton Dickinson's biosciences and diagnostic solutions for $17.5 billion. Initially, the market reacted negatively to this significant deal, which caused a sharp decline in the stock by 13.81%. However, the stock has since rebounded impressively, gaining 45% after the company reported strong quarterly results with an 8% increase in revenue and reassuring full-year forecasts. While some analysts are puzzled by the initial downturn, the overall sentiment suggests that the acquisition may prove beneficial in the long run, especially for Becton Dickinson, which seems to have gained from the stock and debt adjustments. As a result, Waters Corp's stock might be a worthy consideration for investors looking for stability and growth amidst market volatility.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
Lrcx,LRCX
BUY

The stock was doing well into early this year when they combined Becton Dickinson's biosciences & diagnostic solutions business last July. Shares plunged, which he didn't understand, but have since turned around, up 45%. They reported a great quarter last month with revenue up 8% and earnings up as well as its full-year forecast.

COMMENT

It will buy part of BDX for $17.5 billion. The market reacted badly, pushing WAT shares by 13.81% which is too much. It was a good deal for BDX, because of the shares received and the debt paid off.

PARTIAL BUY

Life sciences suffered post-Covid after rallying during Covid. WAT is a major player. Last Wednesday they reperted a clean top/bottom line beat, but issued a cautious earnings forecast, so the market gave a muted reaction. Likes them, because they have few competitors at at time when the economy is slowing down.

BUY
After years of stagnation, WAT brought in a new CEO in Sept. 2020. It nearly doubled in the next 12 months, then pulled back a lot. WAT assists drug and biotech companies, businesses he likes that are putting up excellent quarters.
DON'T BUY

WAT vs. TMO vs. DHR Not performing as well as Thermo Fisher or Danaher. Cash from operations has been flat in the last 4 years, whereas the other two have doubled, which is reflected in the stock price. Market share, operating margins, and pricing power impact the business model. Compare these when assessing competitors in an industry.

Showing 1 to 5 of 5 entries
  • «
  • 1
  • »

Waters Corp (WAT) Frequently Asked Questions

What is Waters Corp stock symbol?

Waters Corp is a American stock, trading under the symbol WAT (previously WAT-N on Stockchase) on the New York Stock Exchange (WAT). It is usually referred to as NYSE:WAT or WAT

Is Waters Corp a buy or a sell?

In the last year, 1 stock analyst published opinions about WAT (previously WAT-N on Stockchase). 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is DON'T BUY. Read the latest stock experts' ratings for Waters Corp.

Is Waters Corp a good investment or a top pick?

Waters Corp was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Waters Corp.

Why is Waters Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Waters Corp worth watching?

1 stock analyst on Stockchase covered Waters Corp in the last year. It is a trending stock that is worth watching.

What is Waters Corp stock price?

On 2026-05-29, Waters Corp (WAT) stock closed at a price of $383.57.